88 related articles for article (PubMed ID: 30092718)
1. SNP rs10800708 within the KIF14 miRNA binding site is linked with breast cancer.
Shasttiri A; Rostamian Delavar M; Baghi M; Dehghani Ashkezari M; Ghaedi K
Br J Biomed Sci; 2019 Jan; 76(1):46-48. PubMed ID: 30092718
[No Abstract] [Full Text] [Related]
2. KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancer.
Wang ZZ; Yang J; Jiang BH; Di JB; Gao P; Peng L; Su XQ
Int J Oncol; 2018 Nov; 53(5):1939-1952. PubMed ID: 30226594
[TBL] [Abstract][Full Text] [Related]
3. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
[TBL] [Abstract][Full Text] [Related]
4. Association of a let-7 KRAS rs712 polymorphism with the risk of breast cancer.
Huang X; Yang Y; Guo Y; Cao ZL; Cui ZW; Hu TC; Gao LB
Genet Mol Res; 2015 Dec; 14(4):16913-20. PubMed ID: 26681038
[TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility.
Nicoloso MS; Sun H; Spizzo R; Kim H; Wickramasinghe P; Shimizu M; Wojcik SE; Ferdin J; Kunej T; Xiao L; Manoukian S; Secreto G; Ravagnani F; Wang X; Radice P; Croce CM; Davuluri RV; Calin GA
Cancer Res; 2010 Apr; 70(7):2789-98. PubMed ID: 20332227
[TBL] [Abstract][Full Text] [Related]
6. KIF14 mRNA expression is a predictor of grade and outcome in breast cancer.
Corson TW; Gallie BL
Int J Cancer; 2006 Sep; 119(5):1088-94. PubMed ID: 16570270
[TBL] [Abstract][Full Text] [Related]
7. Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.
Thériault BL; Pajovic S; Bernardini MQ; Shaw PA; Gallie BL
Int J Cancer; 2012 Apr; 130(8):1844-54. PubMed ID: 21618518
[TBL] [Abstract][Full Text] [Related]
8. KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers.
Corson TW; Huang A; Tsao MS; Gallie BL
Oncogene; 2005 Jul; 24(30):4741-53. PubMed ID: 15897902
[TBL] [Abstract][Full Text] [Related]
9. A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.
Liu Y; Cai H; Liu J; Fan H; Wang Z; Wang Q; Shao M; Sun X; Diao J; Liu Y; Shi Y; Fan Q
Biochem Biophys Res Commun; 2013 Mar; 432(4):660-5. PubMed ID: 23416081
[TBL] [Abstract][Full Text] [Related]
10. rs15869 at miRNA binding site in BRCA2 is associated with breast cancer susceptibility.
Cao J; Luo C; Yan R; Peng R; Wang K; Wang P; Ye H; Song C
Med Oncol; 2016 Dec; 33(12):135. PubMed ID: 27807724
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional and epigenetic regulation of KIF14 overexpression in ovarian cancer.
Thériault BL; Basavarajappa HD; Lim H; Pajovic S; Gallie BL; Corson TW
PLoS One; 2014; 9(3):e91540. PubMed ID: 24626475
[TBL] [Abstract][Full Text] [Related]
12. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset.
Song F; Zheng H; Liu B; Wei S; Dai H; Zhang L; Calin GA; Hao X; Wei Q; Zhang W; Chen K
Clin Cancer Res; 2009 Oct; 15(19):6292-300. PubMed ID: 19789321
[TBL] [Abstract][Full Text] [Related]
13. Involvement of IGF-1R regulation by miR-515-5p modifies breast cancer risk among BRCA1 carriers.
Gilam A; Edry L; Mamluk-Morag E; Bar-Ilan D; Avivi C; Golan D; Laitman Y; Barshack I; Friedman E; Shomron N
Breast Cancer Res Treat; 2013 Apr; 138(3):753-60. PubMed ID: 23549953
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of genetic variations in miRNA-binding sites of BRCA1 and BRCA2 genes as risk factors for the development of early-onset and/or familial breast cancer.
Erturk E; Cecener G; Polatkan V; Gokgoz S; Egeli U; Tunca B; Tezcan G; Demirdogen E; Ak S; Tasdelen I
Asian Pac J Cancer Prev; 2014; 15(19):8319-24. PubMed ID: 25339023
[TBL] [Abstract][Full Text] [Related]
15. KIF14 promotes tumor progression and metastasis and is an independent predictor of poor prognosis in human gastric cancer.
Yang Z; Li C; Yan C; Li J; Yan M; Liu B; Zhu Z; Wu Y; Gu Q
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):181-192. PubMed ID: 30404039
[TBL] [Abstract][Full Text] [Related]
16. KIF14 as an oncogene in retinoblastoma: a target for novel therapeutics?
Basavarajappa HD; Corson TW
Future Med Chem; 2012 Nov; 4(17):2149-52. PubMed ID: 23190103
[No Abstract] [Full Text] [Related]
17. miR-485-5p binding site SNP rs8752 in HPGD gene is associated with breast cancer risk.
He N; Zheng H; Li P; Zhao Y; Zhang W; Song F; Chen K
PLoS One; 2014; 9(7):e102093. PubMed ID: 25003827
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer.
Zhang Y; Yuan Y; Liang P; Zhang Z; Guo X; Xia L; Zhao Y; Shu XS; Sun S; Ying Y; Cheng Y
Oncotarget; 2017 Jul; 8(28):45459-45469. PubMed ID: 28525372
[TBL] [Abstract][Full Text] [Related]
19. Epithelial membrane protein 3 functions as an oncogene and is regulated by microRNA-765 in primary breast carcinoma.
Hong XC; Fen YJ; Yan GC; Hong H; Yan CH; Bing LW; Zhong YH
Mol Med Rep; 2015 Nov; 12(5):6445-50. PubMed ID: 26398721
[TBL] [Abstract][Full Text] [Related]
20. A Polymorphism at the microRNA Binding Site in the 3' Untranslated Region of
Sha Z; Lai R; Zhang X; Zhao Y; Wu J; Geng C; Guo Z
DNA Cell Biol; 2020 Oct; 39(10):1886-1894. PubMed ID: 32678982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
